Literature DB >> 27837912

Cold-inducible RNA binding protein in mouse mammary gland development.

Daniel A Lujan1, Selina Garcia1, Jennifer Vanderhoof1, Joshua Sifuentes1, Yekaterina Brandt1, Yuehan Wu2, Xun Guo1, Therese Mitchell1, Tamara Howard1, Helen J Hathaway1, Rebecca S Hartley3.   

Abstract

RNA binding proteins (RBPs) regulate gene expression by controlling mRNA export, translation, and stability. When altered, some RBPs allow cancer cells to grow, survive, and metastasize. Cold-inducible RNA binding protein (CIRP) is overexpressed in a subset of breast cancers, induces proliferation in breast cancer cell lines, and inhibits apoptosis. Although studies have begun to examine the role of CIRP in breast and other cancers, its role in normal breast development has not been assessed. We generated a transgenic mouse model overexpressing human CIRP in the mammary epithelium to ask if it plays a role in mammary gland development. Effects of CIRP overexpression on mammary gland morphology, cell proliferation, and apoptosis were studied from puberty through pregnancy, lactation and weaning. There were no gross effects on mammary gland morphology as shown by whole mounts. Immunohistochemistry for the proliferation marker Ki67 showed decreased proliferation during the lactational switch (the transition from pregnancy to lactation) in mammary glands from CIRP transgenic mice. Two markers of apoptosis showed that the transgene did not affect apoptosis during mammary gland involution. These results suggest a potential in vivo function in suppressing proliferation during a specific developmental transition. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  A18 hnRNP; CIRP; MMTV-LTR; Mammary gland development; RNA binding protein; Transgenic mouse

Mesh:

Substances:

Year:  2016        PMID: 27837912     DOI: 10.1016/j.tice.2016.10.004

Source DB:  PubMed          Journal:  Tissue Cell        ISSN: 0040-8166            Impact factor:   2.466


  5 in total

Review 1.  Cold-inducible RNA binding protein in cancer and inflammation.

Authors:  Daniel A Lujan; Joey L Ochoa; Rebecca S Hartley
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-01-11       Impact factor: 9.957

2.  A cold-inducible RNA-binding protein (CIRP)-derived peptide attenuates inflammation and organ injury in septic mice.

Authors:  Fangming Zhang; Max Brenner; Weng-Lang Yang; Ping Wang
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

3.  Expression of cold-inducible RNA-binding protein (CIRP) in renal cell carcinoma and the effect of CIRP downregulation cell proliferation and chemosensitivity to gemcitabine.

Authors:  Ke-Wen Zhou; Kun Jiang; Weizhi Zhu; Guobin Weng
Journal:  Oncol Lett       Date:  2018-03-23       Impact factor: 2.967

Review 4.  Recent progress in the research of cold-inducible RNA-binding protein.

Authors:  Peng Zhong; He Huang
Journal:  Future Sci OA       Date:  2017-10-04

5.  Loss of Cirbp expression is correlated with the malignant progression and poor prognosis in nasopharyngeal carcinoma.

Authors:  Tao-Yan Lin; Yan Chen; Jun-Shuang Jia; Chen Zhou; Mei Lian; Yue-Ting Wen; Xiao-Yan Li; Heng-Wei Chen; Xiao-Lin Lin; Xiao-Ling Zhang; Sheng-Jun Xiao; Yan Sun; Dong Xiao
Journal:  Cancer Manag Res       Date:  2019-07-24       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.